Avalo Therapeutics | SC 13G:超過5%持股股東披露文件-Emerald Bioventures, LLC(5.6%),Timothy Opler(5.6%)
04/23 15:00 (美東)
Avalo Therapeutics | D:發行公告
04/09 17:02 (美東)
Avalo Therapeutics | SC 13G:超過5%持股股東披露文件-Deep Track Capital, LP(9.99%),Deep Track Biotechnology Master Fund, Ltd.(9.99%)等
04/05 16:04 (美東)
Avalo Therapeutics | 3:首次持股聲明-董事 Truex Samantha
04/03 16:13 (美東)
Avalo Therapeutics | 3:首次持股聲明-董事 Goldman Jonathan
04/03 16:10 (美東)
Avalo Therapeutics | 3:首次持股聲明-董事 KANTOFF AARON
04/03 16:04 (美東)
Avalo Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Venrock Healthcare Capital Partners III, L.P.(0.0%),VHCP Co-Investment Holdings III, LLC(0.0%)等
02/14 21:18 (美東)
Avalo Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Great Point Partners, LLC(0.26%),Dr. Jeffrey R. Jay, M.D.(0.26%)等
02/14 17:35 (美東)
Avalo Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Nantahala Capital Management, LLC(4.9%),Wilmot B. Harkey(4.9%)等
02/14 16:58 (美東)
Avalo Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Point72 Asset Management, L.P.(0.3%),Point72 Capital Advisors, Inc.(0.3%)等
02/14 10:08 (美東)
Avalo Therapeutics | 4:持股變動聲明-董事 Persson Magnus
2023/12/21 16:05 (美東)
Avalo Therapeutics | 4:持股變動聲明-董事 Almenoff June Sherie
2023/12/21 16:04 (美東)
Avalo Therapeutics | 4:持股變動聲明-董事 KAPLAN GILLA
2023/12/21 16:03 (美東)
Avalo Therapeutics | 4:持股變動聲明-董事 Chan Mitchell
2023/12/21 16:01 (美東)
Avalo Therapeutics | 4:持股變動聲明-董事 Persson Magnus
2023/07/05 16:07 (美東)
Avalo Therapeutics | 4:持股變動聲明-董事 Almenoff June Sherie
2023/07/05 16:05 (美東)
Avalo Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Caissa Capital Management Ltd.(0%),Cambyz Golestaneh(0%)
2023/06/29 08:22 (美東)
Avalo Therapeutics | 4:持股變動聲明-股東 ARMISTICE CAPITAL, LLC
2023/06/28 18:12 (美東)
Avalo Therapeutics | SC 13D/A:超過5%持股股東披露文件(修正)-Steven Boyd(4.99%),Armistice Capital, LLC(4.7%)
2023/06/27 18:02 (美東)
Avalo Therapeutics | 4:持股變動聲明-股東 Caissa Capital Management ltd.
2023/06/27 16:10 (美東)
暫無數據
暫無數據